A Randomised, Double-blind, Parallel Group Study to Assess the Efficacy and Safety of 52 Weeks of Once Daily Treatment of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (2.5 µg / 5 µg; 5 µg / 5 µg) (Delivered by the Respimat® Inhaler) Compared With the Individual Components (2.5 µg and 5 µg Tiotropium, 5 µg Olodaterol) (Delivered by the Respimat® Inhaler) in Patients With Chronic Obstructive Pulmonary Disease (COPD). [TOnado TM 1]

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT01431274

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:35:52.594924+00:00

Published At

2015-07-16T00:00:00+00:00

Record Updated At

2015-07-16

Results Posted At

2015-07-16

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Pulmonary Disease, Chronic Obstructive"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2015-07-16"

protocolSection.identificationModule.nctId

"NCT01431274"

protocolSection.identificationModule.officialTitle

"A Randomised, Double-blind, Parallel Group Study to Assess the Efficacy and Safety of 52 Weeks of Once Daily Treatment of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination (2.5 \u00b5g / 5 \u00b5g; 5 \u00b5g / 5 \u00b5g) (Delivered by the Respimat\u00ae Inhaler) Compared With the Individual Components (2.5 \u00b5g and 5 \u00b5g Tiotropium, 5 \u00b5g Olodaterol) (Delivered by the Respimat\u00ae Inhaler) in Patients With Chronic Obstructive Pulmonary Disease (COPD). [TOnado TM 1]"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE3"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2015-07-16"

Study condition terms

• Pulmonary Disease, Chronic Obstructive (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.